Status:
COMPLETED
Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia
Lead Sponsor:
Ipsen
Conditions:
Idiopathic Cervical Dystonia
Eligibility:
All Genders
18+ years
Brief Summary
A post marketing, international, multicenter, observational, prospective, longitudinal study. The purpose of the study is to describe cervical dystonia sub-types with their injection protocols and res...
Eligibility Criteria
Inclusion
- Idiopathic cervical dystonia
- TWSTRS severity score ≥ 15
- At least a 12-week interval between the last injection (BoNT-A or BoNTB) and inclusion
- Written informed consent prior to collect the data
Exclusion
- Contraindications to any BoNT-A preparations
- Secondary cervical dystonia
- Subject already been included in the study
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
404 Patients enrolled
Trial Details
Trial ID
NCT00833196
Start Date
February 1 2009
End Date
April 1 2010
Last Update
August 16 2019
Active Locations (39)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Prince Alfred Hospital
Camperdown, Australia, NSW 2050
2
St Vincent's Hospital
Fitzroy, Australia, VIC 3065
3
Austin Hospital
Heidelberg, Australia, VIC 3084
4
Westmead Hospital
Penrith, Australia, NSW 2751